2000
DOI: 10.1103/physrevd.63.017302
|View full text |Cite
|
Sign up to set email alerts
|

Heavy neutrino mixing effects in helicity amplitudes for the processμ+μW+

Abstract: The helicity amplitudes for the process ϩ Ϫ →W ϩ W Ϫ are reevaluated with the inclusion of heavy neutrino mixing with the standard light neutrino. The effects of mixing are parametrized as a fractional change ⌬M * in the helicity amplitude for the t-channel exchange. The behavior of ⌬M * is examined. It is found that for a heavy neutrino mass m N ϭ10 GeV and scattering angle ϭ90°, ⌬M * ϭ0.007͉U N ͉ 2 at ͱs ϭ200 GeV and ⌬M * ϭ0.00002͉U N ͉ 2 at ͱsϭ800 GeV. The heavy neutrino mixing effects tend to vanish in the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…By definition, it is related to the existence of two or more crystalline forms of a compound without any alteration to its chemical structure and empirical formula (Gavezzotti, 2007). Polymorphic forms exhibit differences with respect to bioavailability, solubility and the stability of the crystalline forms (Yu et al, 2003), and influence the pharmacokinetics and pharmacodynamics of a drug administered into the body (Singhal & Curatolo, 2004). For example, Rifaximin is a broad spectrum antibacterial drug.…”
Section: Introductionmentioning
confidence: 99%
“…By definition, it is related to the existence of two or more crystalline forms of a compound without any alteration to its chemical structure and empirical formula (Gavezzotti, 2007). Polymorphic forms exhibit differences with respect to bioavailability, solubility and the stability of the crystalline forms (Yu et al, 2003), and influence the pharmacokinetics and pharmacodynamics of a drug administered into the body (Singhal & Curatolo, 2004). For example, Rifaximin is a broad spectrum antibacterial drug.…”
Section: Introductionmentioning
confidence: 99%